Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

3 Stocks to Buy if You're Worried About a Recession
3 Stocks to Buy if You're Worried About a Recession

Recessions create a tough environment to trade stocks in. Very few stocks do well when the economy is spluttering, so the best option for an investor generally is to find someplace to hide their

Analyst Says MGM Resorts Has No Catalysts for Growth in Immediate Future
Analyst Says MGM Resorts Has No Catalysts for Growth in Immediate Future

Casinos may be opening up around the country, but MGM Resorts' (NYSE: MGM) stock is likely to be stuck in place, because there's nothing to move it higher.

Jefferies analyst David Katz downgraded

Is DocuSign Stock a Buy?
Is DocuSign Stock a Buy?

If you've had to sign a document recently, you probably didn't use a pen and paper. You likely encountered the leading e-signature platform from DocuSign (NASDAQ: DOCU) to capture your agreement

Aurora Cannabis Strikes a Deal to Enter the U.S. CBD Market
Aurora Cannabis Strikes a Deal to Enter the U.S. CBD Market

Aurora Cannabis (NYSE: ACB) is making a long-awaited move into the largest legal cannabis market in the world. The marijuana producer announced on Wednesday that it has entered into an agreement to

3 Big Takeaways From Royal Caribbean’s First-Quarter Earnings Call
3 Big Takeaways From Royal Caribbean’s First-Quarter Earnings Call

On Wednesday, May 20, Royal Caribbean (NYSE: RCL) held its first-quarter 2020 conference call with analysts. No one really cared about the cruise company's 16.7% decline in revenue or the $1.48 in

UbiSoft Entertainment Inc. (UBSFY) Q4 2020 Earnings Call Transcript
UbiSoft Entertainment Inc. (UBSFY) Q4 2020 Earnings Call Transcript

Image source: The Motley Fool.

UbiSoft Entertainment Inc. (OTC: UBSFY)Q4 2020 Earnings CallMay 14, 2020, 12:15 p.m. ET

Yves Guillemot

Continue reading

Source Fool.com

Disney World's Top Rival Has a Reopening Plan
Disney World's Top Rival Has a Reopening Plan

The economy has been reawakening in Central Florida after two months of shelter-in-place slumber, and it's time for the country's largest theme-park operators to step up with their reopening plans

Is Applied Materials Stock a Buy?Photo, wide shot, wide-angle lens,  Software company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/70b5df15-67cc-4a1b-af41-3596614daf77.png
Is Applied Materials Stock a Buy?

A lot has changed since Applied Materials (NASDAQ: AMAT) kicked off its 2020 fiscal year with a rebound in sales after a U.S.-China trade war and memory chip market slump the year prior. This time

Could You Use an Extra $2,779 Right Now? Here's How You May Be Able to Get It
Could You Use an Extra $2,779 Right Now? Here's How You May Be Able to Get It

With the COVID-19 crisis occupying so much of the news, it's easy to let a matter like taxes fall by the wayside, especially since the IRS pushed back the filing deadline for 2019 returns to July

4 Reasons Why Streaming Is Faring Better Than Cable During the COVID Pandemic
4 Reasons Why Streaming Is Faring Better Than Cable During the COVID Pandemic

For most industries, the COVID-19 pandemic means that 2020 has been anything but business-as-usual. And, in most industries, that's a bad thing. But some companies and industries have been

Is DCP Midstream Stock a Buy?
Is DCP Midstream Stock a Buy?

DCP Midstream (NYSE: DCP) is a significant player in the North American midstream industry, but units of the MLP have been trading all over the place. At its worst, DCP was down more than 90% in

This Expense Is Costing 40% of Retirees More Than They Expected
This Expense Is Costing 40% of Retirees More Than They Expected

We all hope we're going to remain healthy into our old age, but the truth is, you never can be sure. Even if you eat right and exercise regularly, you never know when an injury will send you to the

Will Good News Boost This Small-Cap Drug Company's Stock Even Higher?
Will Good News Boost This Small-Cap Drug Company's Stock Even Higher?

Shares of CymaBay Therapeutics (NASDAQ: CBAY) have climbed nearly 143% since last week after it got great news about its orphan drug, seladelpar.

A phase 2B trial for the drug to see how it did

Here's How Canada Blew Its Chance to Be a Cannabis Leader
Here's How Canada Blew Its Chance to Be a Cannabis Leader

For years, cannabis stocks were virtually unstoppable. Following a more-than-tripling in worldwide sales between 2014 and 2018 to $10.9 billion, Wall Street and investors sent pot stock valuations

3 Stocks to Hold For the Next 20 Years
3 Stocks to Hold For the Next 20 Years

Ideally, as an investor you should consider holding stocks over years, even decades. The magic of compounding will provide you with a substantial nest egg to enjoy your golden years, while a growing

Disney World and Universal Florida Are Going to Open Faster (and Bigger) Than You Think.
Disney World and Universal Florida Are Going to Open Faster (and Bigger) Than You Think.

Walt Disney (NYSE: DIS) has already opened its Disney Springs shopping area at Walt Disney World. Comcast (NASDAQ: CMCSA) has done the same with its CityWalk shopping area that essentially serves as

Is Your Stimulus Check Not What You Expected? Here Are 6 Reasons Why, the IRS Says
Is Your Stimulus Check Not What You Expected? Here Are 6 Reasons Why, the IRS Says

By now, most Americans have received coronavirus stimulus payments via direct deposit or mail. And for those still waiting, payments should be coming soon. 

These COVID-19 stimulus payments are

Is Alnylam Pharmaceuticals a Buy?Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
Is Alnylam Pharmaceuticals a Buy?

Alnylam Pharmaceuticals (NASDAQ: ALNY) has been a phenomenal biotech stock. The company had its initial public offering in 2004. Shares are now 22 times more valuable than they were 16 years ago

Worried About a Coronavirus-Driven Recession? This Warren Buffett Stock Can Help You Protect Your Wealth
Worried About a Coronavirus-Driven Recession? This Warren Buffett Stock Can Help You Protect Your Wealth

With the coronavirus pandemic crippling the economy -- and more than 30 million Americans losing their jobs -- it's a near certainty that the U.S. will soon fall into a recession.

Many companies

Is Synchrony Financial Stock a Buy?Photo, wide shot, wide-angle lens,  Private equity firm, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/11edc0a6-edfc-46d1-baee-abd4f510abd1.png
Is Synchrony Financial Stock a Buy?

The COVID-19 environment hasn't been particularly kind to bank stocks, with low interest rates and fears of defaulting inducing a strong sell-off. Other types of financial stocks, specifically those

I Had Never Bought a Marijuana Stock -- and Then I Found This Company
I Had Never Bought a Marijuana Stock -- and Then I Found This Company

Marijuana stocks have been a popular trend in the investing world for several years now, but I've avoided the space. Some of the publicly traded cannabis companies were extremely speculative

How a Coronavirus Vaccine Might Move the Stock Market
How a Coronavirus Vaccine Might Move the Stock Market

Many experts think that until an effective vaccine for the SARS-CoV-2 coronavirus is developed and widely deployed, the U.S. economy won't be able to truly return to normalcy.

They're probably

Here's My Top Stock to Buy in May
Here's My Top Stock to Buy in May

During market downturns like the recent coronavirus market crash, it's tempting for investors to spend most of their efforts sifting through beaten-down stocks in search of bargains. But investors

Have $2,000 to Spare? Now Is the Time to Invest It Into This Pet Insurance StockPhoto, wide shot, wide-angle lens, soft focus,  Risk management company, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-vkrXsXVXnZepYEkiT4BvjtCA.png?st=2023-05-14T13%3A27%3A43Z&se=2023-05-14T15%3A27%3A43Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-14T00%3A09%3A01Z&ske=2023-05-15T00%3A09%3A01Z&sks=b&skv=2021-08-06&sig=y1VhH4rrtYGKSVOHO3rBwhpmvE42GCwp7%2BKdLaLI7kA%3D
Have $2,000 to Spare? Now Is the Time to Invest It Into This Pet Insurance Stock

Despite widespread fears that the COVID-19 pandemic would cut consumer spending, Trupanion (NASDAQ: TRUP) has maintained its consumer retention rates as more and more pet owners deem medical

Is Aurora Cannabis Finally Making a Recovery?
Is Aurora Cannabis Finally Making a Recovery?

Aurora Cannabis (NYSE: ACB) used to be one of the biggest names in the cannabis market. However, over the past 12 months, shares have fallen by an astonishing 89% due to a number of concerns, such